• Mallemoggala Sai Babu, Subhash Kaul, Sneha Dadheech, Koppula Rajeshwar, Akka Jyothy, and Anjana Munshi.
• Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Begumpet, India.
• Nutrition. 2013 Jun 1;29(6):872-5.

ObjectivePrevious studies have associated low serum albumin levels with poor outcome in ischemic stroke. Animal studies also demonstrated neuroprotective effects of serum albumin in focal ischemia. However, there are very limited studies on the association of serum albumin levels with stroke outcome in ischemic stroke divided into subtypes. The present study was carried out to investigate the association of serum albumin levels with outcome in ischemic stroke and its subtypes.MethodsThe study involved 560 patients. Serum albumin levels were estimated and follow-up interviews were conducted at 3 mo postevent to determine stroke outcome. The association between serum albumin levels and stroke outcome was evaluated by multiple logistic regression analysis after adjustment for potential confounders.ResultsLow levels of albumin associated significantly with poor outcome (score of >3 on the modified Rankin Scale). The adjusted odds ratio was 1.972 (95% confidence interval, 1.103-4.001; P < 0.001). The recurrence of stroke and death rate also was high in patients with low levels of albumin compared with patients with elevated levels of albumin. The reduced level of serum albumin associated significantly with poor outcome in all the stroke subtypes classified according to TOAST (Trial of ORG 10172 in Acute Stroke Treatment).ConclusionsRelatively high serum albumin levels in acute stroke decrease poor outcome.Copyright © 2013 Elsevier Inc. All rights reserved.

16 keywords...

hide…